These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24718931)

  • 21. Inflammatory response of TLR4 deficient spleen macrophages (CRL 2471) to Brucella abortus S19 and an isogenic ΔmglA deletion mutant.
    Jacob J; Makou P; Finke A; Mielke M
    Int J Med Microbiol; 2016 May; 306(3):141-51. PubMed ID: 26946956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brucella abortus INTA2, a novel strain 19 (Delta)bp26::luc (Delta)bmp18 double mutant lacking drug resistance markers.
    Campos E; Cravero SL; Delgui L; Mora I; Kahn N; Arese AI; Rossetti OL
    Vet Microbiol; 2002 Jun; 87(1):1-13. PubMed ID: 12079742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.
    Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M
    Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping.
    Miranda KL; Poester FP; Minharro S; Dorneles EM; Stynen AP; Lage AP
    Vaccine; 2013 Jun; 31(29):3014-8. PubMed ID: 23664986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brucella abortus tandem repeated ATP-binding proteins, BapA and BapB, homologs of haemophilus influenzae LktB, are not necessary for intracellular survival.
    Ko J; Splitter GA
    Microb Pathog; 2000 Oct; 29(4):245-53. PubMed ID: 10993743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice.
    Mukherjee F; Jain J; Grilló MJ; Blasco JM; Nair M
    Biologicals; 2005 Sep; 33(3):153-60. PubMed ID: 16081301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes.
    Crasta OR; Folkerts O; Fei Z; Mane SP; Evans C; Martino-Catt S; Bricker B; Yu G; Du L; Sobral BW
    PLoS One; 2008 May; 3(5):e2193. PubMed ID: 18478107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation.
    Yu D; Hui Y; Zai X; Xu J; Liang L; Wang B; Yue J; Li S
    Virulence; 2015; 6(8):745-54. PubMed ID: 26039674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a virulence factor for Brucella abortus infection in BALB/c mice.
    Pugh GW; Tabatabai LB; Bricker BJ; Mayfield JE; Phillips M; McDonald TJ; Zehr ES
    Am J Vet Res; 1989 Jun; 50(6):887-92. PubMed ID: 2504086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and protective property of Brucella abortus cydC and looP mutants.
    Truong QL; Cho Y; Barate AK; Kim S; Hahn TW
    Clin Vaccine Immunol; 2014 Nov; 21(11):1573-80. PubMed ID: 25253663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant VirB5 protein as a potential serological marker for the diagnosis of bovine brucellosis.
    Tan W; Wang XR; Nie Y; Wang C; Cheng LQ; Wang XC; Zhang R; Yan GM
    Mol Cell Probes; 2012 Jun; 26(3):127-31. PubMed ID: 22662340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Three Small Proteins in Brucella abortus Linked to Fucose Utilization.
    Budnick JA; Sheehan LM; Kang L; Michalak P; Caswell CC
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29967118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL; Cho Y; Park S; Kim K; Hahn TW
    Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.
    Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S
    J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.
    Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM
    Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and identification of a human domain antibody against Brucella abortus VirB5.
    Deng H; Zhou J; Gong B; Xiao M; Zhang M; Pang Q; Zhang X; Zhao B; Zhou X
    Acta Trop; 2019 Sep; 197():105026. PubMed ID: 31103700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The putative amino acid ABC transporter substrate-binding protein AapJ2 is necessary for Brucella virulence at the early stage of infection in a mouse model.
    Tian M; Bao Y; Li P; Hu H; Ding C; Wang S; Li T; Qi J; Wang X; Yu S
    Vet Res; 2018 Mar; 49(1):32. PubMed ID: 29598830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.
    Manterola L; Moriyón I; Moreno E; Sola-Landa A; Weiss DS; Koch MH; Howe J; Brandenburg K; López-Goñi I
    J Bacteriol; 2005 Aug; 187(16):5631-9. PubMed ID: 16077108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.
    Stevens MG; Olsen SC; Pugh GW
    Infect Immun; 1995 Aug; 63(8):3199-205. PubMed ID: 7622248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipopolysaccharide as a target for brucellosis vaccine design.
    Conde-Álvarez R; Arce-Gorvel V; Gil-Ramírez Y; Iriarte M; Grilló MJ; Gorvel JP; Moriyón I
    Microb Pathog; 2013 May; 58():29-34. PubMed ID: 23219811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.